Cargando…

Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer

Circulating tumor cells (CTCs) with phenotypic hallmarks of epithelial-mesenchymal transition (EMT) reportedly contribute to tumor metastasis in different cancer types. We therefore evaluated the expression of EMT markers in CTCs obtained from a large cohort of Chinese patients with colorectal cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ren, Cai, Zhen, Li, Sheng, Cheng, Yong, Gao, Hua, Liu, Fang, Wu, Shiyang, Liu, Suyan, Dong, Yan, Zheng, Lei, Zhang, Wenbin, Wu, Xiaojun, Yao, Xueqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354732/ https://www.ncbi.nlm.nih.gov/pubmed/28030836 http://dx.doi.org/10.18632/oncotarget.14065

Ejemplares similares

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells
por: Guan, Xiuwen, et al.
Publicado: (2016)

Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients
por: Zhang, Shirong, et al.
Publicado: (2017)

Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance
por: Zhou, Jiaojiao, et al.
Publicado: (2020)

Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance
por: Rapanotti, Maria Cristina, et al.
Publicado: (2023)

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
por: Guan, Xiuwen, et al.
Publicado: (2019)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition
por: Lin, Xiaochang, et al.
Publicado: (2014)

Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition
por: Wu, Yao, et al.
Publicado: (2016)

Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?
por: Fridrichova, Ivana, et al.
Publicado: (2022)

Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer
por: Wu, Fengjie, et al.
Publicado: (2017)

PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice
por: Hong, Xiao-Cui, et al.
Publicado: (2022)

Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer
por: Liu, Hailong, et al.
Publicado: (2020)

Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer
por: Jiang, Sha-Sha, et al.
Publicado: (2021)

Circulating miRNAs Related to Epithelial–Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis
por: Zubrzycka, Anna, et al.
Publicado: (2021)

Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice
por: Zhao, Xiao-Hui, et al.
Publicado: (2019)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
por: Liu, Yankun, et al.
Publicado: (2017)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients
por: Cha, Jiwon, et al.
Publicado: (2023)

Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
por: Fang, Ze-Xuan, et al.
Publicado: (2022)

Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial-mesenchymal transition mediated by the FAK/AKT/MMPs axis
por: Liu, Shi-Quan, et al.
Publicado: (2018)

Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy
por: Lu, Guang, et al.
Publicado: (2021)

Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition
por: Banias, Laura, et al.
Publicado: (2020)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
por: Zvaifler, Nathan J
Publicado: (2006)

Diffusion kurtosis imaging evaluating epithelial–mesenchymal transition in colorectal carcinoma xenografts model: a preliminary study
por: Liu, Huanhuan, et al.
Publicado: (2017)

Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing
por: Kozuka, Masahiro, et al.
Publicado: (2021)

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
por: Li, Y-M, et al.
Publicado: (2013)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients
por: Zhang, Ruiyun, et al.
Publicado: (2020)

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
por: Balcik-Ercin, Pelin, et al.
Publicado: (2021)

Aspirin inhibit platelet-induced epithelial-to-mesenchymal transition of circulating tumor cells (Review)
por: LOU, XIAO-LIANG, et al.
Publicado: (2014)

Analysis of epithelial–mesenchymal transition markers in psoriatic epidermal keratinocytes
por: Man, Xiao-Yong, et al.
Publicado: (2015)

β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition
por: Song, Qing, et al.
Publicado: (2021)

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer
por: Zhang, Wenjing, et al.
Publicado: (2015)

Editorial: Epithelial to Mesenchymal Plasticity in Colorectal Cancer
por: Bocci, Federico, et al.
Publicado: (2022)

Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
por: Lu, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8gtmrhvuarq364bdf9utij0drb